• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Audio Journal of Medicine: Reporting from the 2006 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, San Francisco

  • — 2 Oct, 2006
AudioMedica News
AudioMedica News
Audio Journal of Medicine: Reporting from the 2006 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, San Francisco
Audio Journal of Medicine: Reporting from the 2006 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, San Francisco
00:00 /
RSS Feed
Share
Link
Embed

&t

Jonathan Li
Jonathan Li

Andrew Redmond
Alexander Mankin
Alexander Mankin

Community-Acquired Pneumonia: Short-Course Antibiotic Treatment Good Enough?

REFERENCE: Abstract L-1458
JONATHAN LI, University of California, San Francisco
A large meta-analysis presented at ICAAC supported the idea of giving short-course antibiotic regimens instead of extended-course in community-acquired pneumonia. Derek Thorne got the details from Jonathan Li of the University of California San Francisco.

Could HIV Protease Inhibitors Help Treat or Prevent Malaria?

REFERENCE: Abstract H-1734
ANDREW REDMOND, Royal Brisbane and Women’s Hospital
HIV/AIDS and malaria both kill huge numbers across the globe – and when they’re found together in one person, they become even more dangerous. That’s why ICAAC delegates were interested to see a study looking at the possible antimalarial effects of HIV protease inhibitors. Derek Thorne heard more from Andrew Redmond of the Royal Brisbane and Women’s Hospital.

New Resistance Mechanism in MRSA

REFERENCE: Abstract C1-942
ALEXANDER MANKIN, University of Illinois at Chicago
Methicillin resistant Staphylococcus aureus has once again found a way to develop resistance to an antibiotic – in this case, linezolid – and the mechanism leaves us marveling at nature. Derek Thorne found out more from Alexander Mankin of the University of Illinois at Chicago.

[audio:https://www.audiomedica.com/podcasting/infectious/061002icaac.mp3]

You may also like...

  • DUET 1 and 2 Trials: TMC 125 has Superior Virologic and Immunologic Response Rates DUET 1 and 2 Trials: TMC 125 has Superior Virologic and Immunologic Response Rates 21 Sep, 2007
  • Audio Journal of Medicine – Folate Supplements May Increase Twinning Among Patients Treated with In Vitro Fertilisation Audio Journal of Medicine – Folate Supplements May Increase Twinning Among Patients Treated with In Vitro Fertilisation 21 May, 2006
  • Maraviroc for HIV: Responses at 48 Weeks Maraviroc for HIV: Responses at 48 Weeks 20 Sep, 2007
  • Best Evidence Yet that Folic Acid Fortification Reduces Neural-Tube Defects Best Evidence Yet that Folic Acid Fortification Reduces Neural-Tube Defects 2 Aug, 2007
  • Previous story Audio Journal of Medicine: Reporting from the 2006 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, San Francisco
  • Next story Audio Journal of Cardiovascular Medicine: Sirolimus-Eluting Better Than Uncoated Stents for Primary Angioplasty
  • News

    • Liquid Biopsy ctDNA Prediction of Lung Cancer Relapse “Ready for Prime Time”Liquid Biopsy ctDNA Prediction of Lung Cancer Relapse “Ready for Prime Time”August 4, 2022
    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
  • Related interviews

    • Microbiome Diversity Key To Survival After Allogeneic…
    • Ibrutinib: New Frontline Standard for Chronic Lymphocytic…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • New Front Line Standard for Older Patients with Chronic…
    • CT Screening Cuts Lung Cancer Deaths 24 Per Cent—Second…
  • Home
  • General Medicine
  • Audio Journal of Medicine: Reporting from the 2006 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, San Francisco

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.